If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Gray, or gray market medications, are nothing new, and GLP-1s — the class of weight loss wonder drug that includes ...

In what feels like the biggest health craze in years, weight loss jabs like semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro) have exploded in popularity. GP registrar Dr Jack Mosley ...

His recent medical exam revealed a weight loss attributed to an active lifestyle ... Wegovy, and the newer tirzepatide—are commonly prescribed to treat type 2 diabetes and obesity.

Semaglutide injections like Ozempic have taken the world by storm—praised for their blood sugar-regulating powers and unintended weight loss effects. But while headlines focus on shrinking ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor agonist, has shown promise in promoting weight loss and improving ...

"FDA has never approved any form of tirzepatide for cosmetic weight loss," Lilly's complaint alleges, adding that Lilly makes the only FDA-approved tirzepatide. Henry Meds, Fella Health and Willow ...